title,biorxiv_url
The Role of Ebola Virus VP24 Nuclear Trafficking Signals in Infectious Particle Production,https://www.biorxiv.org/content/10.1101/2024.03.13.584761v1
"The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model",https://www.biorxiv.org/content/10.1101/2024.05.14.594200v1
Pharmacoproteomic profiling identifies secreted markers for aberrant drug action,https://www.biorxiv.org/content/10.1101/2024.10.16.618637v1
Mechanism of SARS-CoV-2 polymerase inhibition by remdesivir,https://www.biorxiv.org/content/10.1101/2020.10.28.358481v1
In-silico Screening of Origanum vulgare Phytocompounds as Potential Drug Agents Against Vp35 Protein of the Ebola Virus,https://www.biorxiv.org/content/10.1101/2023.03.25.534218v1
Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir induces cardiomyocyte dysfunction,https://www.biorxiv.org/content/10.1101/2022.08.08.503256v1
Mechanism and spectrum of inhibition of a 4’-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses,https://www.biorxiv.org/content/10.1101/2024.04.22.590607v1
Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo,https://www.biorxiv.org/content/10.1101/2021.11.17.468980v1
Structure of the Inmazeb cocktail and resistance to escape against Ebola virus,https://www.biorxiv.org/content/10.1101/2022.10.11.511805v1
Chlorpheniramine Maleate Displays Multiple Modes of Antiviral Action Against SARS-CoV-2: A Mechanistic Study,https://www.biorxiv.org/content/10.1101/2023.08.28.554806v1
